Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer-Reference-Cited by-同舟云学术

Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer

Published:2020-07-17 Issue:29 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Zhao Zhen¹^ORCID,Li Yuanke¹^ORCID,Liu Hao¹,Jain Akshay¹,Patel Pratikkumar Vinodchandra¹,Cheng Kun¹^ORCID

Affiliation:

1. Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.

Abstract

Co-delivery of IKBKE siRNA and cabazitaxel inhibits invasiveness and growth of triple-negative breast cancer.

Funder

American Cancer Society

National Cancer Institute

National Institute of General Medical Sciences

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference40 articles.

1. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells;Wang C.;J. Exp. Clin. Cancer Res.,2012

2. Targeting the NFκB signaling pathways for breast cancer prevention and therapy;Wang W.;Curr. Med. Chem.,2015

3. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells;Qin B.;Breast Cancer Res.,2010

4. Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene

5. Identification of an IKBKE inhibitor with antitumor activity in cancer cells overexpressing IKBKE;Liu T.;Cytokine,2019

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in small interfering RNA based therapeutic approach on breast cancer;European Journal of Pharmacology;2024-10

2. HA-modified mesoporous Silica/hydroxyapatite hybrid targeted nanoparticles loaded with cabazitaxel and LY294002 for enhanced treatment of triple-negative breast cancer;Materials Letters;2024-09

3. Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells;Journal of Biomaterials Science, Polymer Edition;2024-08-29

4. Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy;Bioengineering;2024-08-14

5. Construction of cabazitaxel-loaded nanocellulose-clocked mesoporous organosilica nanoparticles for enhanced lung cancer therapy;Process Biochemistry;2024-07